NCT00015951 2019-10-17
Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
University of Maryland, Baltimore
Phase 2 Completed
University of Maryland, Baltimore
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center